Fundraising Fox神州细胞 (Sinocelltech)
1 known investors
Find your way into 神州细胞 (Sinocelltech)
Sign up to see every warm intro you have to 神州细胞 (Sinocelltech)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 神州细胞 (Sinocelltech) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sinocelltech is a biopharmaceutical company founded in 2002 that develops biologic drugs, with five products approved in China and nine additional candidates in clinical development. It is publicly listed in China (stock code 688520).
Founders & leadership
LX
Liangzhi XieFounder
Investors · 1
Qiming Venture Partnerslisted by Qiming Venture PartnersBeijing
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does 神州细胞 (Sinocelltech) do?
- Sinocelltech is a biopharmaceutical company founded in 2002 that develops biologic drugs, with five products approved in China and nine additional candidates in clinical development. It is publicly listed in China (stock code 688520).
- Who are 神州细胞 (Sinocelltech)'s investors?
- 神州细胞 (Sinocelltech)'s investors include Qiming Venture Partners.